StockData
Supernus, Inc. logo

Supernus, Inc. (SUPN) stock

SUPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$28.96−0.08 (-0.28%)

Close on Nov 18, 2026Market cap $3.42BP/E 8.1Yield –

Supernus revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Supernus's revenue for the twelve months ending Sep 30, 2026 was $1.37B, up 16.3% year over year. For fiscal 2025 it was $1.24B, up 4.3% from the year before. The highest annual figure on record is $1.24B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.24B+4.3%
FY2024Dec 31, 2024$1.19B+8.7%
FY2023Dec 31, 2023$1.09B+21.3%
FY2022Dec 31, 2022$901.00M+13.9%
FY2021Dec 31, 2021$791.00M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$356.00M+13.4%
Q2 FY2026Jun 30, 2026$343.00M+13.6%
Q1 FY2026Mar 31, 2026$317.00M+19.2%
Q4 FY2025Dec 31, 2025$358.00M+19.7%
Q3 FY2025Sep 30, 2025$314.00M+2.3%
Q2 FY2025Jun 30, 2025$302.00M+1.0%
Q1 FY2025Mar 31, 2025$266.00M-6.3%
Q4 FY2024Dec 31, 2024$299.00M–
Q3 FY2024Sep 30, 2024$307.00M–
Q2 FY2024Jun 30, 2024$299.00M–
Q1 FY2024Mar 31, 2024$284.00M–

More Supernus figures

See a number that looks wrong?